|
|
 | | | |
- close
- close
- close
- close
TheStreet.com
May 10
Comment
BOSTON (TheStreet) -- This week's Biotech Stock Mailbag is open for business.
@adamfeuerstein SNTA getting hit hard, do you suspect SNTA to respond with a PR/Statement of some sort?Bit hard to ignore, I would think?— Bill H. (@bheafey) May 8,...
StreetInsider.com
May 9
Comment
The following is a list of notable articles to help get you through the lunch hour:
Using Apple's (AAPL) iPad 2 May Be Risky for Some Heart Patients -> Read this!
Record Q1 Profit for Fannie (FNMA) is Boon for U.S. Taxpayers -> Read...
TheStreet.com
May 9
Comment
BOSTON (TheStreet) -- A large study has once again demonstrated the failure of fish oil supplements to reduce heart disease or death in patients at higher risk for heart disease. The negative results of the Italian Risk and Prevention Study,...
StreetInsider.com
Apr 30
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Amarin+%28AMRN%29+Receives+FDA+Approval+for+BASF+sNDA+as+Vascepa+API/8287747.html for the full story.
Benzinga
Apr 24
Comment
U.S. Global Investors (NASDAQ: GROW) shares fell 1.01% to touch a new 52-week low of $2.95. U.S. Global Investors' trailing-twelve-month ROE is 1.51%.
PDI (NASDAQ: PDII) shares dropped 1.76% to reached a new 52-week low of $4.46. PDI's PEG...
StreetInsider.com
Apr 23
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Amarin+%28AMRN%29+sNDA+for+Vascepa+Accepted+by+U.S.+FDA/8269668.html for the full story.
TheStreet.com
Apr 22
Comment
BEDMINSTER, NJ (TheStreet) -- More market exclusivity woes for Amarin and its prescription fish oil pill Vascepa.
I was speaking with an institutional investor last week who made money on Amarin when Vascepa was still in clinical development...
StreetInsider.com
Apr 8
Comment
The following is a list of notable articles to help get you through the lunch hour:
Splitting CEO/Chairman Roles at JPMorgan (JPM) May Cause Dimon to Split -> Read this!
LyondellBasell (LYB) Sees Buying Amid Recent Weakness -> Read...
StreetInsider.com
Apr 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Amarin+%28AMRN%29+Vascepa+Added+to+CVS+%28CVS%29+Health+Plan/8238705.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
This is a test No its not
| |||||||
